Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report
Abstract Background Chronic hepatitis E represents an emerging challenge in organ transplantation, as there are currently no established treatment options for patients who fail to clear hepatitis E virus (HEV) following reduction of immunosuppressive therapy and/or treatment with ribavirin. Sofosbuv...
Main Authors: | Montserrat Fraga, Jérôme Gouttenoire, Roland Sahli, Haithem Chtioui, Cristina Marcu, Manuel Pascual, Darius Moradpour, Julien Vionnet |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12876-019-0995-z |
Similar Items
-
Acute Hepatitis E: Two Sides of the Same Coin
by: Johannes Hartl, et al.
Published: (2016-11-01) -
Prevalence of Hepatitis E Virus Infection among Laboratory Rabbits in China
by: Lin Wang, et al.
Published: (2021-06-01) -
A Hepatitis C Virus-Associated Decompensated Cirrhotic Patient Who Showed the Disappearance of Hepatic Encephalopathy, Ascites, and Pleural Effusion by Antiviral Therapy with Sofosbuvir/Velpatasvir
by: Kazuo Tarao, et al.
Published: (2021-04-01) -
Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study
by: Masanori Atsukawa, et al.
Published: (2020-09-01) -
Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus‐infected patients: Long‐term follow‐up results from the open‐label, Phase II IMPACT study
by: Eric Lawitz, et al.
Published: (2020-06-01)